top of page

Promethean BioPharma supports the rescheduling of psilocybin and MDMA in Australia

Updated: Mar 8, 2022

Promethean BioPharma supports the work of Mind Medicine Australia and encourages their submissions to the Therapeutic Goods Administration in relation to the rescheduling of psilocybin and MDMA from Schedule 9 to Schedule 8.

For more information:

Recent Posts

See All

Cannabis Pill Trial

A world-first cannabis pill is being trialled that could bring relief to millions of people living with chronic pain. If successful, it'll be available over the counter with Australia on track to beco


bottom of page